InStride Health, a pediatric mental health provider, announced Monday that it raised $30 million in Series C funding to expand into new markets. Boston-based InStride Health provides virtual specialty outpatient …
Health
-
-
Health
What’s Flowing Beneath the World Cup: How Verily’s Wastewater Monitoring Could Catch the Next Outbreak
More than 6 million fans are descending on North America this summer for the World Cup, which kicked off last week. They’re arriving from dozens of countries and passing through …
-
As clinical drug development becomes more complex and resource-intensive, the FDA’s recent draft guidance on the use of Bayesian statistical methods in clinical trials signals a move toward more adaptive …
-
AI is rapidly gaining traction in the health insurance industry. But according to one health insurance executive, AI shouldn’t be used for the “sake of AI,” but to empower what …
-
One healthcare finance executive thinks the U.S. healthcare system is on a path toward separate and unequal care. Multicare CFO James Lee said the math that has held the system …
-
The road to interoperability is long, but not impossible. In healthcare, this decades-long effort to improve data sharing has already seen successes, like standardized information-sharing practices and the shift away …
-
Healthcare data is just messy. That’s the simplest way to put it. It doesn’t live in one place, it doesn’t follow one format, and most of the systems it comes …
-
Health
In the Age of AI, Interoperability Isn’t Enough: Why Healthcare Needs Shared Understanding, Not Just Shared Data
Healthcare has made real progress on interoperability, but we are still solving the wrong problem. We have APIs, standards, and more data moving between systems than ever before, yet the …
-
Healthcare costs in the U.S. are growing faster than inflation, and the U.S. spends significantly more than other comparable nations on healthcare. And according to one healthcare executive, this is …
-
Rocket Pharmaceuticals sold its rare disease pediatric priority review voucher for $180 million, cash that the company will use to support a pipeline now led by a gene therapy in …